Pediapharm (PDP) Stock Price, News & Analysis

Company Overview

Pediapharm Inc. operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children. The company was incorporated in 2003 and is headquartered in Verdun, Canada.

Key Stats

• Today's Range: C$0.29 to C$0.31
• 50-Day Range: C$0.30 to C$0.30
• 52-Week Range: C$0.25 to C$0.49
• Volume: 26,000 shs
• Average Volume: 100,369 shs
• Market Capitalization: C$66.36 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PDP Stock Analysis - Frequently Asked Questions

How have PDP shares performed this year?

Pediapharm's stock was trading at C$0.30 on January 1st, 2024. Since then, PDP shares have increased by 0.0% and is now trading at C$0.30.
View the best growth stocks for 2024 here.

How do I buy shares of Pediapharm?

Shares of PDP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Pediapharm own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pediapharm investors own include Medexus Pharmaceuticals (MEDXF), iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX), Enzo Biochem (ENZ), eMagin (EMAN), Eleven Biotherapeutics (EBIO), Coro Mining (COP) and Champion Iron (CIA).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: CVE:PDP
• CUSIP: N/A
• CIK: N/A
• Web: www.pedia-pharm.com
• Phone: +1-514-7622626
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 30.00
• P/E Growth: 150
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 186.87
• Current Ratio: 1.12
• Quick Ratio: 0.71

Sales & Book Value

• Annual Sales: C$11.16 million
• Price / Sales: 5.95
• Cash Flow: C$0.01 per share
• Price / Cash Flow: 23.08
• Book Value: C($0.01) per share
• Price / Book: -23.08

Miscellaneous

• Outstanding Shares: 221,194,000
• Free Float: N/A
• Market Cap: C$66.36 million
• Optionable: Not Optionable
• Beta: N/A